Skip to content

Evaluation of therapeutic effect of thumbtack needle on high altitude insomnia

Evaluation of therapeutic effect of thumbtack needle on high altitude insomnia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006610
Enrollment
Unknown
Registered
2022-09-16
Start date
2022-09-16
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomonia disorder

Interventions

experimental group:thumbtack needle treatment

Sponsors

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Insomnia was diagnosed according to the insomnia disorder standard of the fifth edition of the diagnostic and Statistical Manual of mental diseases (DSM-V); 2. Inclusion criteria: insomniac group inclusion criteria: ? Patients with insomnia as the main complaint, who meet the above diagnostic criteria and have typical symptom groups of insomnia; ? PSQI = 8 points; ? Age = 18 years old; ? They volunteered to participate in this study and signed informed consent.

Exclusion criteria

Exclusion criteria: ? Those who combine with diseases that have not been effectively controlled or are extremely serious, such as persistent pain, malignant tumors, cardiovascular and cerebrovascular diseases, neuroendocrine diseases, neuromuscular diseases and digestive tract diseases caused by various reasons, resulting in insomnia disorders; Comorbid personality disorder or mental retardation; ? Those with severe depression and anxiety (SAS > 70; Self rating Depression Scale (SDS)>73); ? Use alcohol and / or other drugs or dependent drugs; ? Have suffered from depression or other mental diseases within 6 months before enrollment; ? Those who were treated with insomnia drugs within 1 month before enrollment; ? Those who participated in any other clinical trial within 1 month before baseline; ? Pregnant and lactating patients. ? Those who cannot cooperate with the treatment.

Design outcomes

Primary

MeasureTime frame
Difference of Pittsburgh sleep quality index before and after treatment;

Secondary

MeasureTime frame
TCM syndrome questionnaire;Self rating Depression Questionnaire;Metabonomics;Anxiety self rating questionnaire;

Countries

The People's Republic of China

Contacts

Public ContactLIU Jia
marie_liujia@sina.cn18810877011

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026